STOCK TITAN

Isoray To Announce Third Quarter Fiscal 2022 Financial Results on May 10, 2022

(Neutral)
(Neutral)
Tags

Rhea-AI Summary

Isoray, Inc. (NYSE AMERICAN: ISR) will host a conference call on May 10, 2022, at 4:30 p.m. ET to discuss its financial results for Q3 fiscal 2022, ending March 31, 2022. A press release detailing these results will be issued after market close on the same day.

Participants can join the call by dialing (888) 506-0062, or (973) 528-0011 for international callers. The call will be accessible via webcast, available at this link until August 10, 2022.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – ISR

+1.20%
+1.20% Session move

In the trading session that priced this news, ISR gained 1.20%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Conference Call is Tuesday, May 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT

RICHLAND, Wash., April 29, 2022 (GLOBE NEWSWIRE) --  Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference call to discuss its financial results for the third quarter fiscal 2022 ended March 31, 2022 on Tuesday, May 10, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the third quarter fiscal year 2022 after the close of the U.S. stock markets on Tuesday, May 10, 2022.

To listen to the conference call, please dial (888) 506-0062. For callers outside the U.S., please dial (973) 528-0011.

The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/45391. The webcast will be available until August 10, 2022 following the conference call.

About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.


FAQ

What is the date of Isoray's Q3 fiscal 2022 conference call?

Isoray's conference call for Q3 fiscal 2022 is scheduled for May 10, 2022.

How can I access Isoray's conference call?

You can access Isoray's conference call by dialing (888) 506-0062 or through the webcast available at their website.

When will Isoray release their Q3 financial results?

Isoray will issue their Q3 financial results press release after the market closes on May 10, 2022.

What is the end date for Isoray's Q3 fiscal 2022 period?

The Q3 fiscal 2022 period for Isoray ended on March 31, 2022.